Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.045 USD | +2.25% | +4.59% | -31.89% |
May. 30 | Omega Therapeutics, Inc. Announces Termination of Yan Moore as Chief Medical Officer | CI |
May. 29 | Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer | CI |
Business Summary
Number of employees: 94
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Barbara Y. Chan
DFI | Director of Finance/CFO | 60 | - |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 22-03-29 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Mary Szela
BRD | Director/Board Member | 60 | 19-05-31 |
Richard Young
BRD | Director/Board Member | 70 | 17-07-31 |
Michelle Werner
BRD | Director/Board Member | 48 | 23-08-27 |
Elliott Levy
BRD | Director/Board Member | 65 | 21-02-28 |
Rainer Boehm
BRD | Director/Board Member | 63 | 22-08-31 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,154,985 | 50,748,363 ( 92.01 %) | 0 | 92.01 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.89% | 110M | |
+47.12% | 57.87B | |
+41.53% | 40.25B | |
-6.92% | 39.94B | |
-5.96% | 28.54B | |
+12.06% | 26.4B | |
-20.09% | 19.33B | |
+30.27% | 12.4B | |
-0.71% | 12.23B | |
+24.14% | 12.2B |
- Stock Market
- Equities
- OMGA Stock
- Company Omega Therapeutics, Inc.